APT Medical Inc. (SHA:688617)
China
· Delayed Price · Currency is CNY 241.41
-0.41 (-0.17%)
At close: Dec 5, 2025
APT Medical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2017 |
| Operating Revenue | 2,392 | 2,049 | 1,642 | 1,204 | 822.86 | 477.94 | Upgrade
|
| Other Revenue | 16.62 | 16.62 | 8.49 | 11.55 | 5.82 | 1.5 | Upgrade
|
| Revenue | 2,408 | 2,066 | 1,650 | 1,216 | 828.69 | 479.44 | Upgrade
|
| Revenue Growth (YoY) | 22.80% | 25.18% | 35.71% | 46.74% | 72.85% | 18.68% | Upgrade
|
| Cost of Revenue | 664.14 | 579.89 | 486.14 | 354.04 | 259.08 | 142.13 | Upgrade
|
| Gross Profit | 1,744 | 1,486 | 1,164 | 861.98 | 569.61 | 337.3 | Upgrade
|
| Selling, General & Admin | 546.23 | 464.34 | 386.96 | 307.57 | 251.43 | 152.5 | Upgrade
|
| Research & Development | 342.83 | 290.54 | 237.92 | 174.88 | 134.88 | 71.9 | Upgrade
|
| Other Operating Expenses | 19.73 | 15.22 | 14.52 | 13.75 | 8.14 | 6.14 | Upgrade
|
| Operating Expenses | 911.17 | 772.32 | 639.21 | 496.99 | 393.93 | 230.82 | Upgrade
|
| Operating Income | 833.1 | 713.59 | 524.86 | 364.99 | 175.68 | 106.48 | Upgrade
|
| Interest Expense | -1.41 | -2.01 | -3.69 | -1.45 | -1.63 | -0.83 | Upgrade
|
| Interest & Investment Income | 28.49 | 25.23 | 27.74 | 23.94 | 13.26 | 1.21 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.83 | 2.83 | 2.66 | 1.17 | -1 | -0.43 | Upgrade
|
| Other Non Operating Income (Expenses) | 3.29 | -0.82 | -0.04 | -0.49 | -0.5 | -0.33 | Upgrade
|
| EBT Excluding Unusual Items | 866.29 | 738.83 | 551.53 | 388.16 | 185.81 | 106.09 | Upgrade
|
| Impairment of Goodwill | - | - | -3.84 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -17.5 | -16.7 | - | 0.34 | 21.72 | -0.07 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.92 | 0.25 | 11.97 | 0.06 | 0.02 | -0.23 | Upgrade
|
| Asset Writedown | -2.63 | -0.83 | -0.12 | -10.68 | -3.57 | - | Upgrade
|
| Other Unusual Items | 19.71 | 24.42 | 36.83 | 17.25 | 17.58 | 15.42 | Upgrade
|
| Pretax Income | 864.95 | 745.97 | 596.37 | 395.13 | 221.55 | 121.21 | Upgrade
|
| Income Tax Expense | 114.02 | 87.8 | 74.24 | 54.98 | 26.7 | 17.02 | Upgrade
|
| Earnings From Continuing Operations | 750.94 | 658.17 | 522.13 | 340.16 | 194.85 | 104.19 | Upgrade
|
| Minority Interest in Earnings | 17.37 | 14.98 | 11.79 | 17.86 | 13.07 | 6.58 | Upgrade
|
| Net Income | 768.31 | 673.15 | 533.92 | 358.02 | 207.92 | 110.78 | Upgrade
|
| Net Income to Common | 768.31 | 673.15 | 533.92 | 358.02 | 207.92 | 110.78 | Upgrade
|
| Net Income Growth | 16.62% | 26.08% | 49.13% | 72.19% | 87.70% | 34.15% | Upgrade
|
| Shares Outstanding (Basic) | 141 | 140 | 140 | 140 | 137 | 105 | Upgrade
|
| Shares Outstanding (Diluted) | 141 | 141 | 142 | 142 | 138 | 105 | Upgrade
|
| Shares Change (YoY) | -0.09% | -0.52% | -0.16% | 2.99% | 31.45% | -0.29% | Upgrade
|
| EPS (Basic) | 5.45 | 4.80 | 3.82 | 2.56 | 1.52 | 1.06 | Upgrade
|
| EPS (Diluted) | 5.44 | 4.77 | 3.77 | 2.52 | 1.51 | 1.06 | Upgrade
|
| EPS Growth | 16.72% | 26.74% | 49.38% | 67.20% | 42.79% | 34.54% | Upgrade
|
| Free Cash Flow | 569.8 | 93.15 | 487.03 | 224.25 | 14.01 | 104.04 | Upgrade
|
| Free Cash Flow Per Share | 4.04 | 0.66 | 3.44 | 1.58 | 0.10 | 0.99 | Upgrade
|
| Dividend Per Share | 1.207 | 1.207 | 0.951 | 0.785 | 0.476 | 0.238 | Upgrade
|
| Dividend Growth | 26.88% | 26.88% | 21.20% | 65.01% | 100.00% | - | Upgrade
|
| Gross Margin | 72.42% | 71.93% | 70.54% | 70.88% | 68.74% | 70.35% | Upgrade
|
| Operating Margin | 34.59% | 34.54% | 31.81% | 30.01% | 21.20% | 22.21% | Upgrade
|
| Profit Margin | 31.90% | 32.58% | 32.36% | 29.44% | 25.09% | 23.11% | Upgrade
|
| Free Cash Flow Margin | 23.66% | 4.51% | 29.51% | 18.44% | 1.69% | 21.70% | Upgrade
|
| EBITDA | 925.22 | 790.25 | 580.9 | 405.69 | 203.49 | 126.49 | Upgrade
|
| EBITDA Margin | 38.42% | 38.25% | 35.20% | 33.36% | 24.56% | 26.38% | Upgrade
|
| D&A For EBITDA | 92.12 | 76.66 | 56.04 | 40.7 | 27.81 | 20 | Upgrade
|
| EBIT | 833.1 | 713.59 | 524.86 | 364.99 | 175.68 | 106.48 | Upgrade
|
| EBIT Margin | 34.59% | 34.54% | 31.80% | 30.01% | 21.20% | 22.21% | Upgrade
|
| Effective Tax Rate | 13.18% | 11.77% | 12.45% | 13.91% | 12.05% | 14.04% | Upgrade
|
| Revenue as Reported | 2,408 | 2,066 | 1,650 | 1,216 | 828.69 | 479.44 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.